Bendamustine
Back to searchMolecule Structure
Scientific Name
Bendamustine
Description of the Drug
Bendamustine is an antineoplastic agent used for the treatment of chronic lymphocytic leukemia (CLL) and indolent B-cell non-Hodgkin lymphoma (NHL) that has progressed following rituximab therapy.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB06769
http://www.drugbank.ca/drugs/DB06769
Brand Name(s)
Not Available
Company Owner(s)
Mylan Laboratories Ltd, Cephalon Inc, Hospira Inc, Innopharma Licensing Llc, Accord Healthcare Inc, Glenmark Pharmaceuticals Ltd, Eagle Pharmaceuticals Inc, Breckenridge Pharmaceutical Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| DNA | NUCLEIC-ACID | INHIBITOR | CHEMBL2311221 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL26319 | ||||
| Human Metabolome Database | HMDB0248945 | ||||
| DrugBank | DB06769 | ||||
| PubChem: Thomson Pharma | 14901248 | ||||
| PubChem | 65628 | ||||
| NMRShiftDB | 10018223 | ||||
| LINCS | LSM-45554 | ||||
| Nikkaji | J32.486H | ||||
| BindingDB | 173621 | ||||
| EPA CompTox Dashboard | DTXSID2046888 | ||||
| DrugCentral | 302 | ||||
| ChemicalBook | CB5340488 | ||||
| Guide to Pharmacology | 7478 | ||||
| rxnorm | BENDAMUSTINE | TREANDA | BENDEKA | BELRAPZO | BENDAMUSTINE HYDROCHLORIDE |
| ChEBI | 135515 | ||||
| ZINC | ZINC000004214955 |
